Pneumatosis intestinalis associated with lenvatinib during thyroid cancer treatment: a case report
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1752-1947
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pneumatosis intestinalis associated with lenvatinib during thyroid cancer treatment: a case report ; volume:15 ; number:1 ; day:12 ; month:11 ; year:2021 ; pages:1-5 ; date:12.2021
Journal of medical case reports ; 15, Heft 1 (12.11.2021), 1-5, 12.2021
- Urheber
-
Toda, Soji
Iwasaki, Hiroyuki
Murayama, Daisuke
Isoda, Maya
Nakayama, Hirotaka
Suganuma, Nobuyasu
Masudo, Katsuhiko
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13256-021-03158-w
- URN
-
urn:nbn:de:101:1-2022012206501706662241
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Toda, Soji
- Iwasaki, Hiroyuki
- Murayama, Daisuke
- Isoda, Maya
- Nakayama, Hirotaka
- Suganuma, Nobuyasu
- Masudo, Katsuhiko
- SpringerLink (Online service)
Ähnliche Objekte (12)
SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer
Optimal use of lenvatinib in the treatment of advanced thyroid cancer
Conversion surgery after lenvatinib treatment for anaplastic thyroid carcinoma: a case report
Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment – initial experience
Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment – initial experience
Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer
Rechallenge with Lenvatinib after Refractoriness to Initial Lenvatinib Followed by Sorafenib in a Patient with Metastatic Papillary Thyroid Carcinoma
Ulva intestinalis
Pneumatosis intestinalis
Ulva intestinalis
Lamblia intestinalis
Combination of Lenvatinib and Pembrolizumab is an effective treatment option for anaplastic and poorly differentiated thyroid carcinoma
SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer
Optimal use of lenvatinib in the treatment of advanced thyroid cancer
Conversion surgery after lenvatinib treatment for anaplastic thyroid carcinoma: a case report
Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment – initial experience
Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment – initial experience
Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer
Rechallenge with Lenvatinib after Refractoriness to Initial Lenvatinib Followed by Sorafenib in a Patient with Metastatic Papillary Thyroid Carcinoma
Ulva intestinalis
Pneumatosis intestinalis
Ulva intestinalis
Lamblia intestinalis
Combination of Lenvatinib and Pembrolizumab is an effective treatment option for anaplastic and poorly differentiated thyroid carcinoma
SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer
Optimal use of lenvatinib in the treatment of advanced thyroid cancer
Conversion surgery after lenvatinib treatment for anaplastic thyroid carcinoma: a case report
Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment – initial experience
Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment – initial experience
Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer
Rechallenge with Lenvatinib after Refractoriness to Initial Lenvatinib Followed by Sorafenib in a Patient with Metastatic Papillary Thyroid Carcinoma
Ulva intestinalis
Pneumatosis intestinalis
Ulva intestinalis
Lamblia intestinalis